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IntroductIon
Influenza viruses belong to the family Orthomyxoviridae 
and cause millions of cases of severe illness and thousands of 
deaths per year.
We and others recently discovered the linear ubiquitin 
chain assembly complex (LUB AC) to be a critical regulator of 
innate immune signaling and inflammation (Walczak et al., 2012). 
The tripartite LUB AC is comprised of the SHA NK-associated 
RH-domain–interacting protein (SHA RPIN), heme-oxidized 
IRP2 ubiquitin ligase-1 (HOIL-1), and HOIL-1–interacting 
protein (HOIP; Gerlach et al., 2011; Ikeda et al., 2011; 
Tokunaga et al., 2011). To date, LUB AC is the only complex 
known to generate N- to C-terminal—also referred to as 
linear—ubiquitin linkages under native conditions (Kirisako 
et al., 2006).
SHA RPIN-deficient mice suffer from severe chronic 
skin inflammation and several other organ dysfunctions (Ho-
genEsch et al., 1993). Because of their overt skin phenotype, 
they are also known as chronic proliferative dermatitis mice 
(cpdm; HogenEsch et al., 1993). We recently discovered that 
absence of SHA RPIN results in a cell-death–favoring dysreg-
ulation of TNF signaling and that dermatitis of SHA RPIN- 
deficient mice was completely prevented by TNF deficiency, 
implying that in the absence of SHA RPIN, aberrant TNF- 
induced cell death causes cpdm dermatitis (Gerlach et al., 
2011). Subsequently, we and others provided genetic proof for 
this mechanism, as genetic ablation of essential components of 
the TNFR1-induced cell death pathway prevented cpdm der-
matitis (Kumari et al., 2014; Rickard et al., 2014).
the linear ubiquitin chain assembly complex (LuB Ac), consisting of SHA nK-associated rH-domain–interacting protein (SHA rPIn), 
heme-oxidized IrP2 ubiquitin ligase-1 (HoIL-1), and HoIL-1–interacting protein (HoIP), is a critical regulator of inflammation 
and immunity. this is highlighted by the fact that patients with perturbed linear ubiquitination caused by mutations in the 
Hoip or Hoil-1 genes, resulting in knockouts of these proteins, may simultaneously suffer from immunodeficiency and autoin-
flammation. tLr3 plays a crucial, albeit controversial, role in viral infection and tissue damage. We identify a pivotal role of 
LuB Ac in tLr3 signaling and discover a functional interaction between LuB Ac components and tLr3 as crucial for immunity 
to influenza A virus infection. on the biochemical level, we identify LuB Ac components as interacting with the tLr3-signaling 
complex (Sc), thereby enabling tLr3-mediated gene activation. Absence of LuB Ac components increases formation of a pre-
viously unrecognized tLr3-induced death-inducing Sc, leading to enhanced cell death. Intriguingly, excessive tLr3-mediated 
cell death, induced by double-stranded rnA present in the skin of SHA rPIn-deficient chronic proliferative dermatitis mice 
(cpdm), is a major contributor to their autoinflammatory skin phenotype, as genetic coablation of tlr3 substantially amelio-
rated cpdm dermatitis. thus, LuB Ac components control tLr3-mediated innate immunity, thereby preventing development of 
immunodeficiency and autoinflammation.
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Mice lacking HOIL-1 have been reported to present 
with no overt phenotype (Tokunaga et al., 2009) whereas ab-
sence of HOIP, the central LUB AC component, results in 
lethality of developing mouse embryos at day 10.5 of embry-
onic development (Peltzer et al., 2014). Linear ubiquitination 
has further been implicated in prevention of immunodefi-
ciency and autoinflammation, as patients with mutations in 
HOIL-1 or HOIP present with recurrent bacterial infec-
tions and, concomitantly, with hyperinflammation (Bois-
son et al., 2012, 2015).
Members of the TLR family are crucial regulators of in-
flammation and become activated by conserved pathogen-as-
sociated molecular patterns (PAMPs) from bacteria, viruses, 
and fungi (Akira et al., 2006). Equally, endogenous molecules, 
such as high mobility group protein B1, mRNA, or DNA, 
can act as danger signals, or damage-associated molecular pat-
terns (DAMPs), by activating TLRs after their release from 
damaged cells (Rifkin et al., 2005). TLR3, a member of the 
TLR family involved in sensing of both viral infection and 
tissue damage, is activated by double-stranded (ds) RNA, 
which is either generated by viruses during their replication 
cycle acting as a PAMP (Alexopoulou et al., 2001) or released 
from damaged cells as a DAMP (Cavassani et al., 2008; Ber-
nard et al., 2012). TLR3 is a type I transmembrane protein 
and localized in the cell’s endosomal compartment (Matsu-
moto et al., 2014). Ligation of TLR3 by dsRNA results in 
formation of a TLR3-signaling complex (TLR3-SC) across 
the endosomal membrane. This complex activates the follow-
ing different signaling outputs: (i) activation of NF-κB and 
MAPK (Meylan et al., 2004); (ii) induction of type I IFNs 
(Fitzgerald et al., 2003); and (iii) cell death (Feoktistova et al., 
2011; Estornes et al., 2012). Apart from TLR3, the cytosolic 
receptors retinoic acid inducible gene I (RIG-I) and mela-
noma differentiation-associated protein 5 (MDA5) are known 
to sense dsRNA (Takeuchi and Akira, 2009).
Whereas it is clear that TLR3 is involved in the host 
response to viral infection, its precise role remains rather 
poorly defined (Perales-Linares and Navas-Martin, 2013). 
Patients deficient in TLR3 and downstream signaling mol-
ecules, i.e., TIR-domain–containing adapter inducing IFN-β 
(TRIF), TNFR-associated factor (TRAF) 3, TANK-binding 
kinase (TBK) 1, or IFN regulatory factor (IRF) 3, have been 
identified as being highly susceptible to HSV 1 encephalitis 
(Zhang et al., 2007, 2013; Pérez de Diego et al., 2010; San-
cho-Shimizu et al., 2011; Herman et al., 2012; Andersen et 
al., 2015). A missense mutation in the Tlr3 gene was iden-
tified in a patient with influenza A virus (IAV)–associated 
encephalopathy (Hidaka et al., 2006), and TLR3 polymor-
phisms have been associated with development of pneumonia 
in children infected with the H1N1/2009 pandemic strain of 
IAV (Esposito et al., 2012). In contrast, TLR3 deficiency was 
proposed to protect mice from IAV-induced lethal hyperin-
flammation (Le Goffic et al., 2006).
In addition to TLR3′s complex function in sensing viral 
infections, its role in tissue damage is also not fully understood. 
Whereas wound healing and skin regeneration was shown to 
critically depend on TLR3-mediated inflammation (Lai et al., 
2009; Nelson et al., 2015), TLR3 has also been shown to medi-
ate deleterious effects of tissue damage (Cavassani et al., 2008; 
Bernard et al., 2012). Thus, whereas TLR3 is a crucial medi-
ator of various physiological processes ensuring host-protec-
tive immunity and proper wound healing, in both cases the 
outcome of TLR3 signaling can also be deleterious. Hence, 
the TLR3 gene-activatory and cell-death–inducing signaling 
outputs need to be precisely balanced and tightly controlled 
to achieve an adequate physiological response. In situations 
in which this is not the case and the physiological response 
is perturbed, TLR3 activation can cause morbidity or even 
mortality. It is therefore important to fully understand how 
TLR3 signaling is regulated, i.e., which factors are responsible 
for achieving an appropriate response to TLR3 stimulation.
Based on the aforementioned data, we set out to in-
vestigate a possible functional interplay between LUB AC 
components and TLR3 at the physiological, pathological, and 
mechanistic biochemical levels.
reSuLtS
Adequate host response against IAV infection 
requires SHA rPIn and tLr3
Patients with defects in linear ubiquitination caused by mu-
tations in Hoil-1 or Hoip genes resulting in deficiency for 
the respectively encoded proteins are prone to various in-
fections (Boisson et al., 2012, 2015). As linear ubiquitination 
appears to be essential to maintain host protection during 
the course of an infection, we hypothesized that absence 
of SHA RPIN, the third LUB AC component, may influence 
disease outcome after infection by IAV. We therefore infected 
age- and sex-matched WT and SHA RPIN-deficient cpdm 
mice with IAV and monitored their weight for 14 consecu-
tive days after infection. Strikingly, cpdm mice were substan-
tially more susceptible to IAV infection than WT littermates 
(Fig. 1 A). Histological analysis revealed significant presence 
of dead cells and evidence of alveolar damage in the lungs of 
infected cpdm mice, whereas very few dead cells could be 
detected in the lungs of infected WT mice (Fig. 1 B).
IAV is known to induce excessive inflammation via 
production of proinflammatory mediators, including TNF 
(Szretter et al., 2007), and SHA RPIN deficiency has been 
shown to sensitize cells to TNF-induced death (Gerlach et 
al., 2011; Kumari et al., 2014; Rickard et al., 2014). To test 
whether TNF, produced in response to infection, could be 
responsible for the observed aberrant cell death in lungs of 
cpdm mice and thereby contribute to their IAV-induced le-
thality, we treated IAV-infected WT and cpdm mice with the 
TNF blocker Etanercept (a soluble TNFR2-Fc fusion pro-
tein) or vehicle control (Fig.  1  C). Again, cpdm mice lost 
significantly more weight than WT mice but, importantly, this 
additional weight loss was not prevented by TNF inhibition 
(Fig.  1  C) despite autocrine TNF-mediated cell death, in-
duced by caspase inhibitor and Smac Mimetic (SM; He et 
2673JEM Vol. 213, No. 12
Figure 1. Adequate host response against IAV infection requires SHA rPIn and tLr3. (A) Weight of cpdm mice and WT littermate controls (n ≥ 6 
mice per group) infected i.n. with 103 PFU IAV was monitored for 14 consecutive days after infection. (B) Representative H&E stainings of lungs of cpdm 
mice and WT littermate controls noninfected (PBS) or infected i.n. with IAV are shown (lungs of n ≥ 3 mice per genotype and group were analyzed). Alveolar 
damage and dead/dying cells are indicated by asterisk and arrows, respectively. Bars, 100 µm. B, bronchiole. (C) Treatment schedule. cpdm mice and WT 
littermate controls (n ≥ 9 mice per group) were injected i.p. with Etanercept or Pentaglobin as control at a dose of 0.5 mg/mouse 1 d before infection with 
50 PFU IAV, and then every third day. Weight was monitored for 13 consecutive days after infection. (D) HT29 cells were incubated with 50 µg/ml Etaner-
cept before stimulation with 100 nM SM and 20 µM zVAD. Cell viability was assessed after 48 h. Data are presented as means ± SD of three independent 
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al., 2009), being effectively inhibited by Etanercept in vitro 
(Fig. 1 D). Hence, TNF is not responsible for induction of 
aberrant cell death and pathology in IAV-infected cpdm mice.
The presence of TLR3 has been described to be det-
rimental during IAV infection (Le Goffic et al., 2006). Be-
cause IAV-induced death of cpdm mice was independent of 
TNF, we addressed whether the presence of TLR3 may be 
causative for their enhanced susceptibility. We reasoned that, 
if this were the case, then absence of TLR3 should prevent 
lethality. However, when we challenged WT, cpdm, Tlr3−/−, 
and Tlr3−/−.cpdm mice (Fig. 1 E) with IAV, we found that 
TLR3 deficiency failed to protect cpdm mice from IAV-in-
duced lethality. In fact, both, Tlr3−/− and Tlr3−/−.cpdm mice 
were even more susceptible to IAV infection than cpdm mice 
at two different viral doses (Fig. 1, F and G).
The fact that Tlr3−/−.cpdm mice succumbed with sim-
ilar kinetics to IAV infection as Tlr3−/− mice suggests that 
SHA RPIN fulfills its antiviral role by acting downstream of 
TLR3. This conclusion received additional support from our 
analysis of viral titers in the lungs of the respective mouse 
strains after infection. Whereas TLR3 deficiency resulted in 
a drastic increase in viral load, in line with a previous publi-
cation (Le Goffic et al., 2006), SHA RPIN deficiency did not 
interfere with appropriate control of viral propagation as lungs 
of infected cpdm mice displayed viral loads equal to those of 
lungs of infected WT mice (Fig. 1 H). Yet, when TLR3 and 
SHA RPIN were coablated, viral titers were as high as in the 
sole absence of TLR3 (Fig.  1  H). Interestingly, ablation of 
TLR3 or SHA RPIN alone resulted in reduced chemokine 
and interferon-stimulated gene production in the lungs after 
IAV infection as compared with WT mice (Fig. 1  I). Thus, 
whereas in the absence of SHA RPIN, TLR3 can still control 
viral replication, gene-activatory signaling requires the pres-
ence of SHA RPIN and TLR3. Intriguingly, cell death levels 
were increased in the lungs of IAV-infected cpdm mice as 
compared with those in WT, Tlr3−/−, and Tlr3−/−.cpdm mice 
(Fig. 1 J). These results indicate that the increase in cell death 
upon infection with IAV in the lungs of SHA RPIN-deficient 
mice is mediated by TLR3. Thus, both TLR3 and SHA RPIN 
are required to fight infection with IAV.
LuB Ac components are required for tLr3-
mediated gene activation
As the results obtained with Tlr3−/− and cpdm mice in the 
IAV infection model suggested LUB AC involvement in TLR3 
signaling, we next aimed to define the biochemical basis for 
this functional interaction. To study signaling downstream of 
TLR3, a cellular system was required in which signaling in-
duced by administration of the synthetic analogue of dsRNA, 
known as poly(I:C), was dependent on TLR3 and not on the 
cytosolic sensors of dsRNA, RIG-I and MDA5 (Takeuchi 
and Akira, 2009). To test this, we stimulated the human ke-
ratinocyte line HaCaT with and without RNAi-suppressed 
TLR3 expression with poly(I:C). This stimulation resulted in 
cytokine/chemokine secretion (Fig.  2 A) and activation of 
NF-κB, MAPK, and IRF3 (Fig. 2 B) only in TLR3-express-
ing and not in TLR3-suppressed HaCaT cells. Also cell death 
induction by poly(I:C) critically depended on the presence of 
TLR3 (Fig. 2 C). High concentrations of poly(I:C) still re-
sulted in cytokine/chemokine secretion and cell death induc-
tion, albeit at substantially reduced levels. To evaluate whether 
this residual activation was mediated by stimulation of other 
dsRNA-sensing receptors, such as RIG-I or MDA5, we per-
formed RNAi-mediated knockdown of TLR3, RIG-I, and 
MDA5 in parallel in HaCaT (Fig.  2, D–F) and HeLa cells 
(Fig. 2, G–I). Despite efficient knockdown of both receptors 
on the protein level (Fig. 2, F and I), neither RNAi targeting 
of RIG-I nor MDA5 significantly reduced poly(I:C)-induced 
chemokine secretion or cell death, whereas that of TLR3 did 
(Fig. 2, D and E and G and H). Using caspase inhibitors and 
inhibitors of the kinase activity of receptor-interacting pro-
tein (RIP) 1, we next determined that poly(I:C)-induced cell 
death was mainly apoptotic and that caspase inhibition par-
tially converted this death to necroptosis (Fig. 2 J). Caspase-8 
was previously shown to be a component of a signaling com-
plex that forms upon stimulation with poly(I:C) (Feoktistova 
et al., 2011; Estornes et al., 2012). We confirmed this by per-
forming Caspase-8 immunoprecipitation (IP), which revealed 
that RIP1, TRAF6, and cellular inhibitor of apoptosis proteins 
(cIAPs) 1 and 2 associate with Caspase-8 in a poly(I:C) stimu-
lation-dependent manner. Again, this association was entirely 
dependent on the presence of TLR3 (Fig. 2 K). In summary, 
we can conclude that in the cell lines used, poly(I:C) achieves 
its activity by stimulating TLR3.
Having established that all known TLR3 signaling 
outputs were induced by poly(I:C) stimulation in a TLR3- 
dependent manner, we next sought to evaluate the role of 
LUB AC components in enabling or regulating these signaling 
outputs. We first studied whether absence of LUB AC com-
ponents altered TLR3-induced gene activation. RNAi-medi-
ated knockdown of SHA RPIN (Fig. 3 A) or HOIP (Fig. 3 B) 
significantly reduced poly(I:C)-induced secretion of IL-8 and 
TNF. Silencing of SHA RPIN or HOIP in HaCaT cells di-
minished poly(I:C)-induced NF-κB and MAPK activation, 
experiments performed in triplicates. (E) Representative PCR genotyping of experimental mice is shown. (F and G) Weight of WT, cpdm, Tlr3−/−, and Tlr3−/−.
cpdm mice (n ≥ 5 mice per group) infected i.n. with 300 PFU IAV (F) or 100 PFU IAV (G) was monitored for 11 consecutive days after infection. (H and I) IAV 
lung titers (H) and induction of cxcl10 and isg15 by RT-PCR (I) were determined at day 5 after infection (lungs of n ≥ 3 mice per genotype and group were 
analyzed). (J) Representative H&E stainings of lungs of mice of indicated genotypes (n ≥ 3 per genotype and group were analyzed) at day 5 after infection 
or noninfection (PBS) are shown. Dead/dying cells are indicated by arrows. Bars, 100 µm. B, bronchiole. Values are plotted as means ± SEM in A, C, F, and G 
and as means ± SD in D, H, and I. n.d., nondetectable; p.i., post infection. *, P < 0.05; **, P < 0.01; ***, P < 0.001, unpaired Student’s t test.
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Figure 2. tLr3 presence is required to mediate poly(I:c)-induced signaling. (A) HaCaT cells transfected with control or TLR3 RNAi were stimulated 
with poly(I:C) as indicated and concentrations of TNF and IL-8 were determined by ELI SA. (B) HaCaT cells transfected with control or TLR3 RNAi were 
stimulated with 5 µg/ml poly(I:C) as indicated and subjected to analysis by immunoblotting. (C) HaCaT cells transfected with control or TLR3 RNAi were 
stimulated with poly(I:C) as indicated and analyzed for propidium iodide positivity by FACS after 24 h. (D–I) HaCaT cells (D–F) or HeLa cells (G–I) transfected 
with control siRNA or siRNA targeting TLR3, RIG-I, or MDA5 were stimulated with 10 or 100 µg/ml poly(I:C). After 24 h, IL-8 secretion was determined by 
ELI SA (D and G) and loss of cell viability was assessed in parallel (E and H). Knockdown efficiency of MDA5 and RIG-I was determined by immunoblotting (F 
and I). (J) HaCaT cells were preincubated for 1 h with 10 µM 7-Cl-O-Nec-1 (Nec-1), 20 µM zVAD (zVAD), or a combination thereof before stimulation with 
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whereas activation of IRF3 remained largely unaffected 
(Fig.  3, C and D). Interestingly, even though phosphory-
lation of IRF3, a prerequisite of IFN gene expression, was 
largely unaffected in these cells, RNAi-mediated knock-
down of HOIP in HaCaT cells abolished poly(I:C)-induced 
IFN-β secretion (Fig. 3 E).
We next generated knockout cell lines for Hoip (Fig. 3 F) 
to analyze gene-activatory signaling in WT and HOIP-defi-
cient HaCaT and HeLa cells after stimulation with poly(I:C). 
Absence of HOIP consistently resulted in diminished NF-κB 
and ERK activation and consequent reduction in chemokine 
secretion in both cell lines (Fig. 3, G–I). Of note, IRF3 phos-
phorylation was strongly reduced in HOIP-deficient HeLa 
cells, but not in HOIP-deficient HaCaT cells, indicating that 
LUB AC may differentially regulate IRF3 phosphorylation in 
a cell type–specific manner (Fig. 3, G and H).
LuB Ac components limit tLr3-induced cell death
When analyzing whether TLR3-mediated cell death was regu-
lated by LUB AC components, we found that silencing of either 
SHA RPIN or HOIP sensitized cells to TLR3-mediated death 
with absence of HOIP as the central LUB AC component hav-
ing the most pronounced effect (Fig. 4 A). Silencing of HOIP 
did not alter the type of cell death induced by poly(I:C), as it 
remained largely apoptotic (Fig. 4 B). Because poly(I:C) stimu-
lation of HaCaT cells induced secretion of TNF (Fig. 2 A), we 
next addressed whether autocrine TNF might be responsible 
for the observed cell death after TLR3 stimulation by poly(I:C) 
(Haas et al., 2009; Gerlach et al., 2011). However, in line with 
our in vivo results on IAV infection (Fig. 1 C), this was not the 
case. TNF inhibition did not prevent poly(I:C)-induced death 
of HaCaT cells, neither in the presence nor absence of LUB AC 
components (Fig. 4 C), whereas SM/zVAD-induced death of 
HT-29 cells, which is known to be mediated by autocrine TNF 
(He et al., 2009), was blocked (Fig. 1 D). Both HOIP-deficient 
HaCaT and HeLa cells were sensitized to poly(I:C)-induced 
death (Fig. 4, D and E). Further analysis revealed that hall-
marks of apoptosis, including cleavage of Caspase-3 and -8 and 
poly(ADP-ribose) polymerase, were increased in the absence 
of HOIP (Fig. 4, F and G). Importantly, independent of HOIP 
being absent or present, poly(I:C)-induced cell death was 
strictly dependent on the presence of TLR3, as RNAi-medi-
ated knockdown of TLR3 prevented cell death in both HaCaT 
and HeLa cells (Fig. 4, H and I).
LuB Ac components form part of the tLr3-Sc and prevent 
tLr3-induced dISc formation
Having identified LUB AC components as crucial for balanc-
ing TLR3-induced signaling outputs, we next determined 
whether they achieve this by forming part of the TLR3-SC 
induced by poly(I:C) stimulation. To compensate for the fact 
that the native TLR3-SC is of low abundance and therefore 
difficult to analyze after IP, we generated HeLa and HaCaT 
cells stably expressing Flag-tagged TLR3 at intermediate levels 
(HaCaT-TLR3 and HeLa-TLR3 cells; Fig. 5 A) so that acti-
vation of TLR3 signaling still requires ligand-induced receptor 
cross-linking. After stimulation of these cells with poly(I:C), 
we isolated the TLR3-SC by anti-Flag-IP and evaluated it for 
the presence of various factors, including LUB AC components 
(Fig. 5, B and C). This revealed the recruitment of LUB AC 
components to TLR3 upon stimulation with poly(I:C), along 
with components previously implicated in TLR3 signaling, 
such as TRIF, RIP1, TBK1, Fas-associated protein with death 
domain (FADD), and Caspase-8. Importantly, recruitment of 
LUB AC components results in generation of linear ubiquitin 
chains within this complex, as demonstrated by the presence of 
linear ubiquitin, also referred to as Met1 or M1 linkages, after 
poly(I:C) stimulation in the TLR3-SC obtained from both 
HaCaT and HeLa cells (Fig. 5, B and C).
Having identified LUB AC as a novel component of the 
TLR3-SC, we next analyzed how the presence of LUB AC 
components determines composition of this complex (Fig. 5 D). 
This analysis revealed that, apart from preventing recruitment of 
SHA RPIN and HOIL-1 and formation of M1 linkages within 
the TLR3-SC, composition of this complex precipitated from 
HOIP-deficient HeLa cells did not appear to be majorly al-
tered compared with the TLR3-SC precipitated from HeLa 
cells expressing HOIP (Fig. 5 D). Given that TNF induces cell 
death via a second complex that has been proposed to emerge 
from complex I of TNFR1 (Micheau and Tschopp, 2003), we 
hypothesized that TLR3-mediated cell death might also be exe-
cuted from a second signaling platform and that composition of 
such a TLR3-dependent secondary complex might be altered 
by the absence of LUB AC components, thereby providing a 
possible explanation as to how LUB AC prevents cell death. To 
test this hypothesis, we performed Caspase-8-IP after lysates 
were depleted of the TLR3-SC by Flag-IP shown in Fig. 5 C 
and probed for associated proteins implicated in cell death sig-
naling (Fig. 5 E). This experiment indeed revealed the existence 
of a second signaling platform. Importantly, in spite of being 
triggered by activation of TLR3, this complex, which we will 
refer to as TLR3-induced death-inducing signaling complex 
(DISC), was devoid of the receptor (Fig. 5 E). The TLR3-in-
duced DISC contains LUB AC, RIP1, FADD, cIAP1/2, and 
Caspase-8 (Fig. 5 E). In addition, we subjected lysates of HeLa 
cells proficient and deficient in HOIP from the experiment 
in Fig.  5 D to further analysis of the TLR3-induced DISC 
by performing Caspase-8-IP after the TLR3-SC was immu-
50 µg/ml poly(I:C). Propidium iodide positivity was determined by FACS 24 h later. (K) HaCaT cells transfected with control or TLR3 siRNA were stimulated 
with 20 µg/ml poly(I:C) in the presence of 20 µM zVAD. Caspase-8 was immunoprecipitated and coimmunoprecipitated proteins were analyzed by Western 
blot. All values are means ± SD of at least three independent experiments performed in triplicates. *, P < 0.05; **, P < 0.01; ***, P < 0.001, unpaired Student’s 
t test. Western blots are representative of at least two independent experiments. Nonspecific bands are indicated by asterisk.
2677JEM Vol. 213, No. 12
Figure 3. LuB Ac components are required for tLr3-mediated gene activation. (A and B) HaCaT cells transfected with control or siRNA targeting 
SHA RPIN (A) or HOIP (B) were stimulated with poly(I:C) as indicated. Cell supernatants were collected after 24 h of stimulation and concentration of TNF 
and IL-8 was determined by ELI SA. (C and D) HaCaT cells transfected with control or RNAi targeting SHA RPIN (C) or HOIP (D) were stimulated with 5 µg/
ml poly(I:C) as indicated and subjected to analysis by immunoblotting. (E) HaCaT cells transfected with nontargeting or HOIP RNAi were stimulated with 10 
µg/ml poly(I:C). Cell supernatants were collected after 4 h of stimulation and analyzed for concentration of IFN-β by ELI SA. (F) HaCaT Hoip WT and Hoip−/− 
cells and HeLa Hoip WT and Hoip−/− cells were generated, and the absence of HOIP protein was confirmed by Western blotting. Protein levels of SHA RPIN 
and HOIL-1 were determined in parallel. Actin served as loading control. (G and H) HaCaT Hoip WT and Hoip−/− cells (G) or HeLa Hoip WT and Hoip−/− cells 
(H) were stimulated with 5 µg/ml poly(I:C) as indicated and subjected to analysis by immunoblotting. (I) HaCaT and HeLa Hoip WT and Hoip−/− cells were 
stimulated with poly(I:C) as indicated. Cell supernatants were collected 24 h later and analyzed for concentration of CCL5 by ELI SA. All values are means ± 
SD of at least three independent experiments performed in triplicates. *, P < 0.05; **, P < 0.01; ***, P < 0.001, unpaired Student’s t test. Western blots are 
representative of at least two independent experiments. Nonspecific bands are indicated by asterisk.
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noprecipitated via Flag. Formation of the TLR3-induced 
DISC was markedly enhanced in the absence of HOIP as 
association of RIP1, cIAP1/2, and FADD with Caspase-8 
was substantially increased in HOIP-deficient cells, whereas 
LUB AC components and M1 linkages were also absent 
from this complex (Fig. 5 F). Together, these results demon-
strate that absence of LUB AC and linear ubiquitin from 
the TLR3-SC results in an aberrant increase in formation 
of the TLR3-induced DISC.
LuB Ac components regulate tLr3 signaling induced by 
poly(I:c) ex vivo and in vivo
Having identified the presence of LUB AC components in the 
TLR3-SC, and in the newly described TLR3-induced DISC, 
as crucial for a balanced TLR3 signaling output in vitro in cell 
lines, we next investigated the role of LUB AC components in 
TLR3 signaling in primary cells. As TLR3 signaling has been 
shown to be involved in skin homeostasis (Lai et al., 2009; 
Nelson et al., 2015), we used primary murine keratinocytes 
Figure 4. LuB Ac components limit tLr3- 
induced cell death. (A) HaCaT cells trans-
fected with control, SHA RPIN, or HOIP siRNA 
were stimulated with poly(I:C) as indicated 
and loss of cell viability was determined after 
24 h. (B) HaCaT cells transfected with control 
or HOIP siRNA were incubated with 10  µM 
7-Cl-O-Nec-1 (Nec-1), 20  µM zVAD (zVAD), 
or a combination thereof 1  h before stim-
ulation with 1 µg/ml poly(I:C). Loss of cell 
viability was assessed after 24  h. (C) HaCaT 
cells transfected with control or HOIP siRNA 
were incubated in the presence or absence of 
50 µg/ml Etanercept 2  h before stimulation 
with 100 µg/ml poly(I:C). Loss of cell viability 
was determined after 24  h. (D and E) HaCaT 
Hoip WT and Hoip−/− cells (D) and HeLa Hoip 
WT and Hoip−/− cells (E) were stimulated with 
poly(I:C) as indicated. Loss of cell viability was 
assessed after 24 h. (F and G) HaCaT Hoip WT 
and Hoip−/− cells (F) or HeLa Hoip WT and 
Hoip−/− cells (G) were stimulated with 5 µg/ml 
poly(I:C) as indicated and subjected to further 
analysis by immunoblotting. (H) HaCaT Hoip 
WT and Hoip−/− cells were transfected with 
control RNAi or RNAi targeting TLR3. Cells 
were stimulated with 1 µg/ml and loss of cell 
viability was assessed after 24 h. (I) HeLa Hoip 
WT and Hoip−/− cells were transfected with 
control or TLR3 siRNA. Cells were stimulated 
with 100 µg/ml and loss of cell viability was 
assessed after 24 h. All values are presented as 
means ± SD of at least three independent ex-
periments performed in triplicates. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001, unpaired Student’s t 
test. Images are representative of at least two 
independent experiments.
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Figure 5. LuB Ac components form part of the tLr3-Sc and prevent tLr3-induced dISc formation. (A) HaCaT parental and Flag-tagged TLR3- 
expressing cells and HeLa parental and Flag-tagged TLR3-expressing HeLa Hoip WT and Hoip−/− cells were lysed, and levels of TLR3 (by staining for Flag), HOIP, 
HOIL-1, and SHA RPIN were determined by immunoblotting. Actin served as loading control. (B) HaCaT-TLR3 cells were stimulated with 20 µg/ml poly(I:C) in 
the presence of 20 µM zVAD as indicated. Cells were subsequently lysed and TLR3 was immunoprecipitated via Flag and coimmunoprecipitated proteins were 
analyzed by immunoblotting. Levels of Flag-tagged TLR3 were determined by staining for TLR3. (C) HeLa cells stably expressing Flag-TLR3 were incubated in the 
presence of 20 µM zVAD before stimulation with 20 µg/ml poly(I:C) as indicated. TLR3 was immunoprecipitated via its Flag-tag and analysis of coimmunoprecip-
itated proteins by immunoblotting was performed as indicated. (D) HeLa Hoip WT and Hoip−/− cells stably expressing Flag-TLR3 were stimulated with 20 µg/ml 
poly(I:C) in the presence of 20 µM zVAD and TLR3 was immunoprecipitated via Flag and coimmunoprecipitated proteins were analyzed by immunoblotting. 
(E) Caspase-8-IP was performed after lysates were depleted of the TLR3-SC by Flag-IP (C), and coimmunoprecipitated proteins were analyzed by immunoblot-
ting. (F) Caspase-8-IP was performed after lysates were depleted of the TLR3-SC by Flag-IP (shown in D) and coimmunoprecipitated proteins were subjected 
to analysis by immunoblotting. Images are representative of at least three independent experiments. M1, linear ubiquitin linkages.
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(PMKs) isolated from newborn WT versus cpdm mice as the 
primary cell model to assess the role of LUB AC components 
in TLR3 signaling ex vivo. After determining that WT PMKs 
express SHA RPIN protein, whereas cpdm–derived PMKs 
do not (Fig.  6 A), we compared chemokine secretion upon 
poly(I:C) stimulation from cpdm- and WT-derived PMKs. In 
line with the in vitro results obtained in cell lines, cpdm PMKs 
were found to secrete significantly less chemokines than WT 
PMKs when stimulated with poly(I:C) (Fig. 6 B). Upon stimu-
lation with poly(I:C), cpdm PMKs were significantly sensitized 
to poly(I:C)-induced cell death (Fig. 6 C). Poly(I:C)-induced 
chemokine secretion was strictly dependent on presence of 
TLR3, independent of whether SHA RPIN was absent or 
present (Fig. 6 D). Moreover, PMKs with inducible deletion 
of HOIP (Fig.  6 E) exhibited reduced chemokine secretion 
(Fig.  6  F) along with a significant increase in poly(I:C)-in-
duced cell death (Fig. 6 G), demonstrating that HOIP limits 
TLR3-mediated death of PMKs ex vivo. These experiments 
were performed using PMKs from 4-hydroxy-tamoxifen 
(4-OHT)-inducible Hoipfl/fl Cre+ mice.
We next evaluated whether absence of SHA RPIN in-
fluences TLR3 signaling in response to poly(I:C) in vivo. For 
this purpose, we injected poly(I:C) into the ear pinnae of WT 
and cpdm mice. In line with our ex vivo results, cytokine 
and IFN-β mRNA induction was significantly suppressed 
in the ear pinnae of cpdm mice (Fig.  6  H). Intradermal 
stimulation with poly(I:C) is dependent on the presence 
of TLR3, as injection of poly(I:C) into the ear pinnae of 
TLR3-deficient mice resulted in significantly reduced IFN-β 
mRNA induction (Fig. 6 I).
tLr3 deficiency ameliorates cpdm dermatitis
In this study, we identified a crucial role for LUB AC compo-
nents in TLR3-mediated host protection against IAV infec-
tion. However, TLR3 has also been implicated in the sensing 
of tissue damage (Brentano et al., 2005; Cavassani et al., 2008; 
Bernard et al., 2012). Intriguingly, cpdm mice were previ-
ously shown to display increased cell death in the skin even 
before onset of inflammation (HogenEsch et al., 1993) and 
we subsequently showed that TNF is the trigger of this early 
cell death (Gerlach et al., 2011; Kumari et al., 2014; Rickard 
et al., 2014). This, together with our discovery that the pres-
ence of LUB AC components prevents TLR3-induced DISC 
formation and, consequently, TLR3-induced cell death, led 
us to develop the following hypothesis: release of dsRNA as 
a DAMP from TNF-killed keratinocytes in the skin of cpdm 
mice could trigger further release of dsRNA, resulting in 
stimulation of TLR3, which, in the absence of SHA RPIN, 
would further increase cell death.
To test this hypothesis, we first analyzed cpdm skin 
sections for the presence of dsRNA. Staining with a dsR-
NA-specific antibody showed that dsRNA is indeed highly 
abundant in cpdm, whereas it is virtually absent from WT 
skin (Fig. 7 A). To address whether deregulated TLR3 signal-
ing in the absence of SHA RPIN might serve as an inflam-
mation accelerant by triggering additional release of DAMPs 
from cells dying as a consequence of TLR3 ligation, we next 
assessed dsRNA presence in the skin of Tlr3−/− and Tlr3−/−.
cpdm mice (Fig.  7  A). Interestingly, release of dsRNA, al-
though clearly detectable, was significantly diminished in 
Tlr3−/−.cpdm skin, indicating that TLR3 stimulation indeed 
exacerbates DAMP release (Fig. 7 A). These results imply that, 
in the skin of cpdm mice, TLR3 serves as both damage sensor 
and amplifier of inflammation.
To test whether deregulation of TLR3 signaling in the 
absence of SHA RPIN indeed contributes to cpdm patho-
genesis, we coablated the Tlr3 gene and evaluated whether 
this resulted in amelioration of dermatitis induced by 
SHA RPIN deficiency. Strikingly, this was the case, as TLR3 
deficiency markedly attenuated skin inflammation in cpdm 
mice (Fig. 7 B, C). Genetic coablation of Tlr3 also signifi-
cantly reduced epidermal thickness in cpdm mice (Fig. 7 D). 
Furthermore, skin sections of Tlr3−/−.cpdm mice were less 
inflamed and displayed less hyperkeratosis and parakeratosis 
than those of cpdm mice (Fig. 7 E).
Further characterization of these skin sections revealed 
that keratin 10, normally expressed in terminally differentiat-
ing epidermal keratinocytes, is expressed in WT and Tlr3−/− 
mice but absent from cpdm skin. Interestingly, co-deficiency 
in TLR3 restored keratin 10 expression (Fig. 7 E). Expression 
of loricrin, an additional marker of terminally differentiated 
epidermal cells, was found in WT and Tlr3−/− mice. Whereas 
cpdm skin lacked expression of loricrin, it was present in the 
skin of Tlr3−/−.cpdm mice (Fig. 7 E). Interestingly, keratin 6, 
a marker expressed by keratinocytes that undergo rapid turn-
over and thus serve as an indicator of proliferation, was highly 
expressed in cpdm keratinocytes, whereas almost no keratin 
6 expression was detectable in Tlr3−/−.cpdm skin (Fig. 7 E). 
Staining of skin sections for CD45 revealed that immune cell 
infiltration of cpdm skin was also markedly reduced in the 
absence of TLR3 (Fig. 7 E).
We next assessed the extent of cell death in the skin of 
the different mice. Although TUN EL and cleaved Caspase-3 
positivity was detectable in both cpdm and Tlr3−/−.cpdm skin 
(Fig.  7 E), quantification revealed that coablation of TLR3 
resulted in disappearance of the majority of cell death in the 
skin of cpdm mice (Fig. 7 F).
dIScuSSIon
In this study, we discover an intricate mechanistic interac-
tion between LUB AC components and activated TLR3 at 
the biochemical level, with profound immunological conse-
quences on host response to viral infection and development 
of autoinflammation. The role of TLR3 in innate sensing of 
IAV is not entirely clear (Perales-Linares and Navas-Martin, 
2013). A missense mutation in the Tlr3 gene was identified 
in a patient with IAV-associated encephalopathy (Hidaka 
et al., 2006), and children with TLR3 polymorphisms have 
an increased risk of pneumonia when infected by the pan-
demic A/H1N1/2009 influenza virus (Esposito et al., 2012). 
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Figure 6. LuB Ac components regulate tLr3 signaling induced by poly(I:c) ex vivo and in vivo. (A) SHA RPIN protein expression of PMKs from WT 
mice (n = 2) and cpdm (n = 4) littermates was analyzed by Western blot. Actin served as loading control. (B) PMKs isolated from newborn WT (n = 2) and 
cpdm (n = 4) littermates were stimulated by poly(I:C) as indicated. Concentrations of murine CCL5 (mCCL5) and murine CCL20 (mCCL20) in the supernatants 
were determined by ELI SA after 24 h of stimulation. One representative of two independent experiments performed in triplicates is shown. (C) PMKs from 
WT mice (n = 2) and cpdm littermates (n = 2) were isolated at the age of 4 wk and cells were stimulated with 50 µg/ml poly(I:C) in absence versus presence of 
250 ng/ml CHX. Loss of cell viability was determined after 48 h of stimulation. One representative of two independent experiments performed in triplicates 
is shown. (D) PMKs from cpdm+/− (n = 3), Tlr3−/−.cpdm+/− (n = 3), and Tlr3−/−.cpdm−/− (n = 3) littermates isolated at the age of 4 wk were stimulated with 100 
µg/ml poly(I:C) and concentration of mCCL5 was determined in the supernatant after 24 h by ELI SA. (E) HOIP protein expression of PMKs isolated from one 
litter of newborn Cre+ Hoipfl/fl mice (n = 4) cultured in absence versus presence of 1 µM 4-OHT for at least 72 h was analyzed by Western blot. Actin served as 
loading control. (F) PMKs with 4-OHT–inducible deletion of HOIP from Cre+ Hoipfl/fl newborn littermates (n = 4) were stimulated with poly(I:C) as indicated. 
Concentrations of mCCL5 and mCCL20 were determined by ELI SA after 24 h of stimulation. One representative of two independent experiments performed 
in triplicates is shown. (G) Loss of cell viability was determined in parallel. (H) Naked poly(I:C) was injected into the ear pinnae of WT and cpdm littermates 
(n = 5) and induction of il6 and ifnb mRNA was assessed by RT-PCR. (I) Naked poly(I:C) was injected into the ear pinnae of WT and Tlr3−/− littermates (n = 5) 
and ifnb mRNA level was assessed by RT-PCR. Values are plotted as means ± SD for the indicated number of mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001, 
unpaired Student’s t test. Images are representative of at least two independent experiments.
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Le Goffic et al. (2006) reported that TLR3 deficiency pro-
tects mice against H3N2 IAV infection despite elevated viral 
titers and diminished chemokine production in the lungs of 
TLR3-deficient mice during infection, although this was 
later suggested to be strain specific (Leung et al., 2014). Here, 
we establish further that the presence of TLR3 is crucial for 
the initiation of an adequate antiviral immune response to in-
fection with the IAV strain A/Puerto Rico/8/1934 (H1N1).
We show that both TLR3 and SHA RPIN are required 
to initiate an adequate host response to IAV infection. TLR3 is 
indispensable for IAV-induced gene activation and control of 
viral load, as viral particles replicate uncontrolled in its absence. 
SHA RPIN maintains gene activation and prevents excessive 
cell death upon infection with IAV. In the absence of both 
TLR3 and SHA RPIN, no control of viral load is achieved, 
no gene activation initiated, and no cell death observed. This 
Figure 7. tLr3 deficiency ameliorates cpdm dermatitis. (A) Representative images of dsRNA staining (J2) in the skin of 8-wk-old WT, Tlr3−/−, cpdm, 
and Tlr3−/−.cpdm littermates are shown (two independent experiments, n = 3 per genotype). (B) Representative pictures of 8-wk-old littermates of indicated 
genotypes are shown. (C) Severity scoring of dermatitis was assessed at the age of 8 wk. Dots represent scoring of individual mice ± SD. (D) Quantification 
of epidermal thickness of mice of indicated genotype (n = 3 per genotype) is shown. (E) Representative H&E, keratin 14/10, loricrin, keratin 6, CD45, and 
TUN EL/cleaved Caspase-3 stainings of skin sections of 8-wk-old WT, Tlr3−/−, cpdm, and Tlr3−/−.cpdm littermates are shown (three independent experiments, 
n ≥ 3 per genotype). Bar, 50 µm. (F) Quantification of TUN EL-positive cells and cleaved Caspase-3-positive cells in the skin sections of indicated genotypes 
is shown (n ≥ 3 per genotype). *, P < 0.05, **, P < 0.01, unpaired Student’s t test.
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shows that TLR3 acts upstream of SHA RPIN and, impor-
tantly, that the increased cell death in response to IAV infection 
in SHA RPIN-deficient mice is indeed caused by triggering 
of TLR3. Interestingly, although SHA RPIN is required to 
control TLR3-mediated signaling outputs, viral control is not 
altered in SHA RPIN-deficient as compared with WT mice. 
One plausible explanation for these findings could be that in 
the absence of SHA RPIN, diminished TLR3-induced gene 
activation would result in an increase of viral replication but 
that this is limited by increased TLR3-mediated cell death in 
the lungs of SHA RPIN-deficient mice. Thus, sensitization to 
TLR3-mediated cell death in the absence of SHA RPIN may 
be beneficial to the extent that it enables control of viral rep-
lication, as infected and possibly also bystander cells are more 
prone to die. However, when the initial viral dose is too high, 
damage to the lungs of SHA RPIN-deficient mice, possibly 
caused by excessive TLR3-mediated cell death, is incompat-
ible with survival and results in diminished disease tolerance. 
Thus, whereas at lower viral doses TLR3-induced cell death 
may contribute to antiviral immunity, when the viral titer 
surpasses a certain limit, this cell death may become harm-
ful and eventually lethal.
On the biochemical level, we identify LUB AC as a novel 
component of the dsRNA-induced TLR3-SC. LUB AC 
components are required in this complex for enabling 
TLR3-induced gene activation and subsequent secretion of 
chemo- and cytokines. In addition, IFN-β secretion critically 
depended on the presence of HOIP. Interestingly, and con-
trary to the role of LUB AC components in TLR3-mediated 
type I IFN production identified in this study, it has been 
claimed that LUB AC negatively regulates virus-induced type I 
IFN production via degradation of tripartite motif-containing 
protein 25 in the RIG-I–signaling pathway (Inn et al., 2011). 
Type I IFN production in RIG-I signaling is mediated by 
IRF3. IRF3 has recently been shown to be involved in 
RIG-I–mediated induction of apoptosis after viral infection. 
Interestingly, this process was shown to require linear ubiq-
uitination of IRF3 (Chattopadhyay et al., 2016), suggesting 
opposing roles for LUB AC in RIG-I– versus TLR3-medi-
ated apoptosis, as we demonstrate that LUB AC prevents ab-
errant TLR3-induced cell death without regulating the type 
of death. Absence of LUB AC components therefore perturbs 
the balance of TLR3′s signaling outputs by reducing gene ac-
tivation and enhancing cell death. TLR3-SC analysis revealed 
recruitment of various endogenous proteins to the TLR3-SC, 
including the three LUB AC components. Mechanistically, 
we show that ligation of TLR3 results in formation of the 
TLR3-SC, leading to gene activation in a LUB AC compo-
nent–dependent manner. Subsequently, a previously unrecog-
nized TLR3-induced DISC, which is devoid of TLR3, forms 
and triggers cell death. In HOIP-deficient cells, formation 
of this DISC, and consequently TLR3-induced cell death, is 
substantially enhanced. This provides the molecular explana-
tion of how LUB AC limits cell death induction by TLR3. We 
propose that the TLR3-induced DISC forms subsequently 
to the TLR3-SC by dissociation of part of the TLR3-SC 
from the receptor over time. This proposed model is sup-
ported by the observations that the kinetics of formation of 
the TLR3-SC precedes that of the TLR3-induced DISC and 
that TLR3 is absent from the TLR3-induced DISC. Notably, 
because of this sequence of events TLR3 signaling appears 
to parallel TNFR1 signaling in which complex II, originat-
ing from the TNFR1-SC, which is known to induce gene 
activation, was identified to induce cell death (Micheau and 
Tschopp, 2003). However, although the data provide compel-
ling support for a transition from complex I to complex II in 
TLR3 signaling, it cannot be excluded that these complexes 
form sequentially, yet independently, of each other. Thus, as 
for TNFR1 signaling, formal proof for provenience of com-
plex II from complex I remains to be provided.
Related to this matter, poly(I:C)-induced cell death 
was previously shown to be mediated by a platform con-
taining Caspase-8, RIP1, cIAPs, TRIF, and TLR3 (Estornes 
et al., 2012; Weiss et al., 2013). In addition, cIAPs have been 
identified to prevent formation of a poly(I:C)-induced sig-
naling platform termed Ripoptosome consisting of RIP1 as 
its core component, Caspase-8, and TRIF (Feoktistova et al., 
2011). These studies isolated the poly(I:C)-induced signaling 
complex by Caspase-8-IP. We show here that Caspase-8 is 
only transiently associated with TLR3 and that it dissociates 
from the receptor over time to form part of the TLR3-in-
duced DISC. Our results demonstrate the stimulation- and 
HOIP-dependent presence of linear ubiquitin linkages in 
both, the TLR3-SC and the TLR3-induced DISC. It remains 
to be determined, however, which of these complexes’ in-
dividual components are modified by M1-linked ubiquitin.
Recently, cIAP2 was identified as crucial for protection 
against IAV-induced host lethality (Rodrigue-Gervais et al., 
2014). In this study, the authors proposed that IAV infection 
results in secretion of TRA IL and CD95L, which were at least 
partially responsible for cell death induction of lung epithelial 
cells in the absence of cIAP2. Because we identified cIAPs 
to form part of the TLR3-induced DISC, we postulate that 
deregulated TLR3 signaling, with a signaling output shifted 
toward cell death in the absence of cIAP2, is likely to contrib-
ute to IAV-induced lethality in this scenario.
TLR3 has recently been implicated in skin regeneration 
and wound healing by serving as DAMP sensor (Lai et al., 
2009; Nelson et al., 2015), in addition to serving as a PAMP 
sensor. Here, we show that, in the absence of SHA RPIN, 
deregulated TLR3 signaling contributes to the pathogene-
sis of cpdm dermatitis, as genetic ablation of TLR3 signifi-
cantly ameliorates dermatitis of SHA RPIN-deficient mice. 
We demonstrate that dsRNA is highly abundant in inflamed 
skin of cpdm mice, whereas there is significantly less dsRNA 
in Tlr3−/−.cpdm skin, suggesting that the presence of TLR3 
serves as an accelerant of the disease caused by absence of 
SHA RPIN. Importantly, TNF deficiency completely pre-
vented inflammation in cpdm mice (Gerlach et al., 2011), 
whereas genetic ablation of Tlr3, though exerting a substan-
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tial effect, only ameliorated it. We therefore propose a model 
according to which absence of SHA RPIN results in TNF-in-
duced death of keratinocytes (Gerlach et al., 2011), inducing 
an initial release of different DAMPs, including dsRNA, in 
turn resulting in activation of TLR3, which, in the absence 
of SHA RPIN, triggers further release of DAMPs, includ-
ing more dsRNA, because of a further increase in aberrant 
cell death. As TNF-induced cell death results in release of all 
different kinds of DAMPs, it is likely that apart from TLR3, 
other damage sensors also play a role in fueling the inflam-
mation in SHA RPIN-deficient mice, which explains why 
absence of TLR3, though substantially ameliorating cpdm 
skin inflammation, fails to completely rescue the phenotype 
in contrast to TNF deficiency. According to this model, this 
sequence of events ultimately results in a self-perpetuating, 
TLR3/dsRNA-driven cycle of chronic inflammation and 
tissue malfunctioning in the skin of cpdm mice. It is tempting 
to speculate that the disease etiology in cpdm mice proposed 
by this model may provide an explanation as to why certain 
autoimmune patients do not respond to anti-TNF therapy, 
even though TNF could still be the initial trigger.
In this study, we demonstrate that SHA RPIN is involved 
in host protection against IAV infection by serving a crucial 
role in TLR3 signaling and that TLR3 contributes to the au-
toinflammatory skin phenotype that characterizes SHA RPIN- 
deficient cpdm mice. Interestingly, this co-occurrence of im-
paired host defense and autoinflammation caused by dereg-
ulation of TLR3 signaling in mice deficient in SHA RPIN, is 
reminiscent of the severe pathological syndrome observed in 
some of the patients with knockout mutations in either of the 
other two LUB AC components, HOIP and HOIL-1 (Bois-
son et al., 2012, 2015). The autoinflammatory phenotype of 
SHA RPIN-deficient mice is, however, characterized by severe 
skin inflammation, whereas the described patients deficient in 
HOIL-1 or HOIP appear not to suffer from inflammatory 
skin symptoms. Notably, human patients with deficiency in 
SHA RPIN have not yet been described. Two independent 
studies identified truncating mutations in HOIL-1 to be 
causative for a phenotype encompassing muscular weakness, 
progressive cardiomyopathy, and signs of amylopectinosis; 
however, none of the patients suffered from severe immuno-
deficiency or overt hyperinflammation (Nilsson et al., 2013; 
Wang et al., 2013). The authors speculated that this discrep-
ancy to the LUB AC-deficient patients described by Boisson 
et al. (Boisson et al., 2012, 2015) may result from different 
sites of the mutations. Variability seen in the phenotype of pa-
tients with the same genetic disorder may also come from the 
human virome, as suggested by MacDuff et al. (2015), who 
showed that chronic viral infection results in activation of the 
innate immune system thereby complementing immunode-
ficiency of mice deficient in e.g., HOIL-1 to bacterial infec-
tions. To answer the question whether the immunodeficient 
and autoinflammatory phenotypes of HOIP/HOIL-1–defi-
cient patients are related to, or completely independent of, 
the immunodeficient and autoinflammatory phenotypes of 
SHA RPIN-deficient mice will require further analysis. Based 
on our results, we suggest that deregulated TLR3 signaling 
may contribute to the immunodeficiency and autoinflam-
mation observed in patients with LUB AC deficiency, and, 
although none of the patients with LUB AC deficiency iden-
tified so far suffered from IAV infection, we propose that out-
come of TLR3-triggering viral infections may be worse in 
patients with deficiency in LUB AC components.
MAterIALS And MetHodS
reagents
The following antibodies were used: α-pIκBα (IgG1), α-IκBα 
(rabbit), α-pERK (rabbit), α-ERK (rabbit), α-pJNK (rabbit), 
α-JNK (rabbit), α-pIRF3 (Ser396; rabbit), and α-pTBK1 (rab-
bit) were purchased from Cell Signaling Technology; α-actin 
(IgG1), α-FLAG (IgG1), and α-human-HOIP (rabbit) were 
obtained from Sigma-Aldrich; α-mouse-HOIP (rabbit) was 
custom-made by Thermo Fisher Scientific; α-MDA5 (rabbit) 
was purchased from Thermo Fisher Scientific; α-HOIL-1 
(IgG2a) and α-SHA RPIN (IgG1) are previously described 
(Haas et al., 2009; Gerlach et al., 2011); α-SHA RPIN (rabbit) 
was purchased from Proteintech; α-Caspase-8 (C15; IgG2b), 
α-cFLIP (NF6; IgG1), and α-FADD (IgG1) were obtained 
from Enzo Life Sciences; α-TRAF6 (C-term; rabbit) was pur-
chased from Epitomics; α-PARP (IgG1) and α-RIP1 (IgG2a) 
were purchased from BD; α-Caspase-3 (goat), α-HOIP (IgG1), 
and α-cIAP1/2 (IgG2a) were obtained from R&D Systems; 
α-GAP DH (IgG1) was purchased from Abcam; α-linear 
Ubiquitin (1E3; rabbit) was obtained from Merck; α-RIG-I 
(rabbit) was obtained from IBL; and α-IKKγ (FL419; rabbit) 
was purchased from Santa Cruz Biotechnology, Inc.
α-Caspase-8 (goat; Santa Cruz Biotechnology, Inc.) and 
α-FLAG (IgG1; Sigma-Aldrich) were used for IP experi-
ments. α-J2 (English & Scientific Consulting Kft.), α-K14, 
α-K10, α-K6, and α-loricirin (Covance), α-cleaved Caspase-3 
(Cell Signaling Technology), and α-CD45 (BD) were used 
for immunofluorescence. α-TLR3 (IgG1) was provided by S. 
Lebecque (Centre de Recherche en Cancérologie de Lyon, 
INS ERM Unité Mixte de Recherche 1052/CNRS 5286, 
Centre Léon Bérard, Lyon, France).
Secondary antibodies for Western blot were purchased 
from Southern Biotech. Alexa Fluor 488 and 594 goat α-rab-
bit IgG were purchased from Invitrogen, and goat α-rat HRP 
was obtained from Cambridge Bioscience.
Poly(I:C) HMW was purchased from InvivoGen; 
z-VAD(OMe)-FMK was obtained from Abcam; and 7-Cl-
O-Nec-1 was obtained from Millipore. Smac Mimetic 083 
(SM083) was provided by M. Bolognesi (Protein Biochem-
istry Unit, Department of Biosciences, University of Milano, 
Milano, Italy). Etanercept (Enbrel) was purchased from Pfizer, 
and Pentaglobin was obtained from Biotest.
Primers
The following primers were used: il6, forward, 5′-GTA GCT 
ATG GTA CTC CAG AAG AC-3′, and reverse 5′-ACG ATG 
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ATG CAC TTG CAG AA-3′; ifnb, forward, 5′-CAT CAA CTA 
TAA GCA GCT CCA-3′, and reverse, 5′-TTC AAG TGG 
AGA GCA GTT GAG-3′; cxcl10, forward, 5′-ACT GCA TCC 
ATA TCG ATG AC-3′, and reverse, 5′-TTC ATC GTG GCA 
ATG ATC TC-3′; hprt, forward 5′-GTT GGA TAC AGG 
CCA GAC TTT GTTG-3′, and reverse, 5′-GAT TCA ACT 
TGC GCT CAT CTT AGGC-3′; and isg15, forward, 5′-GCA 
AGC AGC CAG AAG CAG ACT CC-3′ and reverse, 5′-CGG 
ACA CCA GGA AAT CGT TAC CCC-3′.
culture of cell lines
The human immortalized keratinocyte line HaCaT, the 
human colon adenocarcinoma grade II cell line HT29, and 
the cervical cancer cell line HeLa were maintained in DMEM 
supplemented with 10% FCS. Parental cell lines were tested 
on a regular basis and determined to be mycoplasma free 
using MycoAlert Mycoplasma Detection kit (Lonza).
retroviral transduction of cells
For tagging of exogenously expressed proteins, we used a 
C-terminal Tandem Affinity Purification-tag consisting of 2x 
Strep-tag II sequence followed by a PreScission cleavage site 
and 1x Flag-tag. Coding sequences for TLR3 fused at the C 
terminus to a Tandem Affinity Purification-tag were inserted 
into the retroviral murine stem cell virus vector, followed by 
an internal ribosome entry site and the open reading frame of 
enhanced green fluorescent protein. These vectors were trans-
fected using Lipofectamine 2000 in Phoenix cells cultured in 
DMEM supplemented with 10% FCS. 1 d after transfection, 
the medium was replaced and subsequently collected at day 
three. Viral supernatants were passed through a 0.45-µm filter 
and added to HaCaT or HeLa cells in the presence of Poly-
brene at 6 µg/ml before cells were subjected to spin-infection 
(2,500 rpm, 45 min, 30°C). EGFP-positive cells were isolated 
using MoFlo FACS (Beckman Coulter) to >95% purity.
Generation of Hoip−/− cell lines
For production of Hoip−/− HaCaT and HeLa cells, LentiCRI 
SPR version 2 vector (F. Zhang, Broad Institute of MIT and 
Harvard, Cambridge, MA; plasmid #52961; Addgene; Sanjana 
et al., 2014) targeting the following sequence was used: 5′-
CGA GAT GTG CTG CGA TTA TA-3′.
Lentiviral particles were produced in HEK293FT cells 
upon co-transfection of LentiCRI SPR vector together with 
packaging vectors psPAX2 and pMD2G. Cells were infected 
as in the case of retroviral transduction and subjected to pu-
romycin (2 µg/ml) selection for 1 wk. Single-cell cloning was 
achieved by limiting dilution, and HOIP-deficient cells were 
validated by Western blotting.
cell viability and cell death assays
Cell viability was determined using Cell Titer Glo assay 
(Promega) according to the manufacturer’s instructions. Cell 
death was determined by percentage of propidium iodide– 
positive cells.
Western blot analysis
Cells were washed twice with ice-cold PBS before lysis in 
lysis buffer containing 30 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 2 mM EDTA, 2 mM KCl, 10% Glycerol, 1% Triton 
X-100, 1× complete EDTA-free protease-inhibitor mix 
(Roche), and 1× phosphatase-inhibitor cocktail 2 (Sigma-Al-
drich). Protein concentration of lysates was determined using 
BCA protein assay (Thermo Fisher Scientific). Lysates were 
denatured in reducing sample buffer at 95°C for 10 min be-
fore separation by SDS-PAGE (NuPAGE), and analyzed by 
Western blotting. Membranes were incubated with primary 
antibodies at 4°C overnight or for 1 h at room temperature. 
Washing of membranes was performed in 1xPBS contain-
ing 0.05% Tween-20 (Sigma-Aldrich) for 3 × 10 min be-
fore incubation with the secondary antibody for 1 h at room 
temperature. Membranes were stripped with stripping buffer 
containing 50  mM glycine, pH 2.3, before reprobing with 
the next primary antibody.
IP
Cells were seeded at 0.5–107 cells in 150 cm2 dishes. The next 
day, cells were stimulated as indicated in DMEM without FCS. 
Cells were washed twice with ice-cold PBS and harvested in 
0.5 ml lysis buffer containing 100 mM NaCl, 40 mM Tris-
HCl, pH 7.5, 1 mM CaCl2, 1 mM MgCl2, and 1× complete 
EDTA-free protease-inhibitor mix supplemented with 0.5% 
Triton X-100. Cells were lysed for 20 min by gentle rocking 
at 4°C. Lysates were subsequently cleared by centrifugation at 
13,000 rpm for 10 min and transferred to a new Eppendorf 
tube. The remaining pellets were resuspended in 0.5 ml of 
lysis buffer supplemented with 1% Triton X-100 and 0.1% 
SDS and subjected to sonification before centrifugation at 
13,000 rpm for 20 min. The cleared lysate was added to the 
lysate of centrifugation step 1. 30 µl of lysates were subse-
quently stored at −20°C for analysis of whole-cell lysates. For 
IP of Flag, 10 µl of M2 beads (Sigma-Aldrich) were added to 
each sample. For IP of Caspase-8, 10 µl Protein-G beads that 
were precoupled to Caspase-8 antibody were added to each 
sample. Samples were incubated at 4°C for 8–24 h. For IP of 
Caspase-8 after IP of Flag, lysates were cleared by centrifuga-
tion from M2 beads, and Protein-G beads that were precou-
pled to Caspase-8 were added to each sample and incubated 
for 8–24 h at 4°C. Samples were washed at least five times 
with lysis buffer containing 1% Triton X-100. After the last 
centrifugation step, beads were sucked dry and resuspended 
in 2x reducing sample buffer, boiled for 10 min at 95°C, and 
separated by SDS-PAGE before analysis by Western blotting.
eLI SA
Cells were stimulated as indicated for 4 h (IFN-β) or 24 h 
(IL-8, TNF, CCL5, and CCL20). Cell supernatants were sub-
sequently collected and stored at −20°C until further analy-
sis. DuoSet ELI SA for human α-IL-8, human α-TNF, human 
and murine α-CCL5, and murine α-CCL20 were purchased 
from R&D Systems. Human IFN-β was determined using 
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the VeriKine human IFN-β ELI SA kit (PBL Assay Science). 
The respective ELI SA was performed according to the man-
ufacturer's instructions.
rnA interference
Cells were plated in 6-well plates at a seeding density of 
1.2 × 105 cells/well before transfection by the respective 
siRNAs using Lipofectamine 2000 transfection reagent (In-
vitrogen) for HaCaT or using DharmaFECT transfection 
reagent (Dharmacon) for HeLa according to the manufac-
turer's instructions. siRNA sequences targeting the gene of 
interest were purchased from Dharmacon (Non-Targeting 
siRNA [sequence #3], human HOIP siRNA [sequence 
#4], human SHA RPIN siRNA [ON-TAR GETplus SMA 
RTpool], human HOIL-1 siRNA [ON-TAR GETplus 
SMA RTpool], human TLR3 siRNA [ON-TAR GETplus 
Set of 4 Upgrade {sequences #5–#8}], human RIG-I 
siRNA [ON-TAR GETplus Set of 4 Upgrade {sequences 
#5–#8}], and human MDA5 siRNA [ON-TAR GETplus 
Set of 4 Upgrade {sequences #5–#8}]). Cells were reseeded 
48 h after transfection and subjected to further experimen-
tal analysis 24 h later.
Mice
Tlr3−/− (9675, B6N.129S1-Tlr3tm1Flv/J), cpdm (7599, C57BL/
KaLawRij-Sharpincpdm/RijSunJ), and Tamoxifen-inducible 
Cre mice (4682, B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J) were 
obtained from The Jackson Laboratory. HOIP-floxed mice 
were generated as previously described (Peltzer et al., 2014). 
HOIP-floxed mice were crossed with transgenic mice express-
ing the Tamoxifen-inducible loxP-deleter Cre recombinase to 
generate Tamoxifen-inducible HOIP-deficient mice. All mice 
were crossed for at least five generations before the experi-
mental studies. All mice were typed by PCR analysis. Colonies 
were fed ad libitum. All animal experiments were conducted 
under an appropriate UK project license in accordance with 
the regulations of UK home office for animal welfare accord-
ing to the ASPA (Animals [Scientific Procedures] Act 1986).
Isolation and culture of PMKs from newborn mice
PMKs were isolated according to the protocol established 
and described in detail by Lichti et al. (2008) from new-
born littermates at the age of 0–2 d. In summary, newborn 
mice were humanely killed and their skin was floated on 
trypsin (Cellgro) at 4°C overnight. The next day, epidermis 
was separated from dermis and PMKs were isolated using 
high-calcium medium (HiCa medium, 1.3 mM Ca2+). After 
isolation, PMKs were counted and seeded at equal numbers 
in low-calcium medium (LoCa medium, 0.05  mM Ca2+). 
24 h after plating, dead cells were removed by washing once 
with DPBS (Invitrogen). Fresh LoCa medium was subse-
quently added. Medium was changed every other day until 
cells reached 70–90% confluency, usually between day 3 and 
5 after plating. For PMKs from Tamoxifen-inducible Cre 
HOIPfl/fl newborn littermates, 4-OHT (Sigma-Aldrich) was 
added to the medium at a concentration of 1 µM directly 
after isolation for at least 72 h.
Isolation and culture of PMKs from tails of adult mice
Tails of littermates were wiped with 70% Ethanol, and then 
removed at base and carefully incised using a scalpel to make a 
longitudinal incision down the tail; skin was subsequently re-
moved from the tails using tweezers. Skin was then incubated 
overnight at 4°C in keratinocyte serum free media (from In-
vitrogen) with dispase II at a final concentration of 2.1 U/ml 
to cleave epidermal–dermal junctions. The next day, epider-
mis was separated from dermis. Epidermis was then incubated 
for 15 min in 2 ml TrypLE express trypsin (from Invitrogen) 
to isolate keratinocytes. After addition of medium, cells were 
centrifuged at 600 rpm for 10 min. Supernatant was removed 
and the pellet was resuspended in medium supplemented 
with bovine pituitary extract and epidermal growth factor, 
including gentamicin at 50 µg/ml (Sigma-Aldrich). Floating 
dead cells were removed the next day. Keratinocytes were 
then grown to 70–90% confluency until further experiments 
were performed, usually after 3–5 additional days in culture.
Histology
Skin or lungs were removed, fixed in 10% formalin, and then 
transferred to 70% ethanol. Paraffin embedding, preparation 
of sections and H&E staining of tissues were performed by 
histological services at the National Heart & Lung Institute 
(London, England, UK) or the Department of Pathology, 
University of Cambridge (Cambridge, England, UK).
Immunofluorescence
Skin sections were de-waxed and rehydrated by passing the 
slides through xylene and descending grades of alcohol, then 
rinsed in water. Antigen retrieval was performed by immersing 
sections in 10 mM sodium citrate buffer, pH 6.0. Sections 
were washed and then blocked for at least 30 min with TBS 
1x, pH 7.6, containing Tween-20 0.5% and BSA 0.2% in a 
humid chamber. For CD45 staining, Retrievagen A (BD) was 
used for antigen retrieval. Slides were incubated with 100 µl 
of the primary antibody overnight at 4°C. The following anti-
bodies were used: α-K14 (Covance), α-K10 (Covance), α-K6 
(Covance), α-loricirin (Covance), and α-CD45 (BD) using 
the following dilutions: K14 1:1000, K10 1:500, K6 1:500, 
loricrin 1:500, and CD45 1:20. On the day after, slides were 
washed and subsequently incubated with the secondary anti-
body Alexa Fluor 488 (Invitrogen) or 594 goat α-rabbit IgG 
(Invitrogen) or goat α-rat HRP (Cambridge Bioscience) at 
room temperature for 1 h at a dilution of 1:500. Where HRP 
antibody was applied, the TSA Plus Cyanine 3 System (Perkin 
Elmer) was applied according to the manufacturer’s instruc-
tions. Sections were extensively washed and counterstained 
with 1:2,000 DAPI (Roche) to visualize the nuclei. Sections 
were mounted with StayBrite Hardset Mounting Medium 
(Biotium Inc.) and analyzed by fluorescent microscopy. At 
least 10 different images (40×) for each slide were acquired.
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dsrnA staining with J2 antibody
Slide deparaffinization was performed by incubating the slides 
at 60°C. Slides were subsequently immersed in histoclear, fol-
lowed by incubation in decreasing concentrations of ethanol 
and subsequent washing of the slides in water. Antigen retrieval 
was performed using EDTA buffer (1 mM EDTA, pH 8.0). 
Subsequent treatment of slides with H2O2 3% for 10 min was 
performed to block endogenous peroxidases. Blocking of un-
specific sites was performed using TBS 1x, pH 7.6, containing 
Tween 20 0.05%, BSA 0.2%, and goat serum 10%. Staining 
with the J2 antibody (English & Scientific Consulting Kft.) was 
performed diluting the antibody in TBS 1x, pH 7.6, containing 
Tween 20 0.05%, BSA 0.2%, and goat serum 10% to a final con-
centration of 1 µg/ml for 2 h. Afterward, slides were incubated 
with the secondary antibody α-mouse IgG2a-HRP (1:1,000) 
for 1 h at room temperature. TSA amplification system Cy3 
(Promega) was added. Finally, nuclei were stained using DAPI 
dye 1:1,000. Slides were subsequently mounted with 10 µl 
Everbright mounting medium and sealed with a coverslip. At 
least 10 different images (40×) for each slide were acquired.
tun eL and cleaved caspase-3 staining
Sections were immersed in 10 mM sodium citrate buffer, pH 
6.0, for antigen retrieval. Slides were washed with water and 
blocked with 1x PBS containing 10% goat serum at room 
temperature for 20 min. Subsequently, slides were incubated 
with anti-cleaved Caspase-3 (Cell Signaling Technology) di-
luted 1:100 in 1.5% goat serum in PBS 1x at room tem-
perature for 1 h. After washing, sections were incubated with 
rabbit biotinylated antibody (Vector) 1:200 diluted in 1.5% 
goat serum in PBS 1x at room temperature for 45 min. Slides 
were washed and incubated with streptavidin conjugate Cy2 
(Jackson ImmunoResearch Laboratories) diluted 1:200 in 
1.5% goat serum in PBS 1x and counterstained with DAPI 
1:1,000 at room temperature. Next, slides were washed and 
ApopTag Red In Situ Apoptosis Detection (Merch Millipore) 
protocol was applied according to the manufacturer’s instruc-
tions. Slides were mounted with StayBrite Hardset Mounting 
Medium (Biotium Inc.) and analyzed by fluorescent micros-
copy. At least 10 different images (40×) for each slide were 
acquired and quantification was performed with ImageJ Soft-
ware (National Institutes of Health) on monochrome images 
counting the DAPI-positive cells in the epidermis and cells 
positive for the specific staining within the epidermis.
epidermal thickness quantification
The epidermal thickness was measured in five different po-
sitions per field and for at least 10 different fields per mouse. 
Quantification was performed using ImageJ Software.
In vivo rnA stimulation
1 µg poly(I:C) in 10  µl PBS was injected i.d. into the ear 
pinnae of age- and sex-matched littermates of the indicated 
genotypes (n ≥ 5 per time point), and induction of innate 
immune transcriptional responses was assessed by RT-PCR 
analysis of extracted RNA after 12 h. Data are presented as 
fold-induction relative to the hprt gene.
IAV infection
IAV strain A/PR/8 was grown and titrated on Madin Darby 
canine kidney cells. For weight loss experiments, age- and 
sex-matched WT, cpdm, Tlr3−/−, and Tlr3−/−.cpdm litter-
mates (4–5 wk old) were anaesthetized and infected i.n. with 
the indicated dose of IAV, and their weights were monitored 
daily. Etanercept (or Pentaglobin as mock control) was ad-
ministered at a concentration of 0.5 mg/mouse/injection. In-
jections were started 1 d before the infection and then every 
third day for 2 wk. For analysis of lung pathology, age- and 
sex-matched littermates (n ≥ 10 per group; 4–5 wk old) were 
infected i.n. with IAV and lung tissue was harvested at the 
indicated times after infection and fixed in formalin for histo-
logical processing or frozen for further analysis. For RT-PCR, 
frozen lung tissue was ground under liquid nitrogen and total 
cellular RNA was extracted using an RNeasy kit (QIA GEN). 
cDNA synthesis was performed with Superscript III Reverse 
transcription (Life Technologies) using 500 ng of template 
RNA. RT-PCR was performed on a 7900HT series ther-
mocycler (Life Technologies) with Fast SYBR Green Master 
Mix (Life Technologies). Hprt was used as the reference gene 
in all assays. Data were analyzed with RQ manager 1.2 soft-
ware (Life Technologies). For IAV titrations, serial dilutions of 
lung homogenates of known mass were incubated on mono-
layers of Madin Darby canine kidney cells for 1 h before being 
overlayed with medium containing 0.5% agarose and 0.1 µg/
ml TPCK-trypsin (Worthington Biochemical Corporation). 
Plaques were counted 3–4 d later and data are presented as 
virus titer per milligram of lung tissue. For histological analy-
sis, lungs were fixed in 10% formalin before being transferred 
into 20% ethanol before paraffin embedding. Hematoxylin 
and eosin (H&E) staining was performed and at least 10 dif-
ferent images (40×) for each slide were acquired for analysis.
Severity of dermatitis
Severity of dermatitis of cpdm mice and WT littermate con-
trols was assessed at the age of 8 wk on six different body 
parts (head, neck, anterior trunk, posterior trunk, fore-
legs, and hind legs) in a blinded manner. The score was ob-
tained by grading each of the six body parts lesion absent (0 
points) or lesion detectable (1 point), accounting to a maxi-
mum of six points/mouse.
Microscope image acquisition
All microscopic images were acquired using an Axio Imager 
A1 microscope (EC Plan-neofluar Air; magnification 40×; 
NA, 0.75; ZEI SS) at room temperature (20°C). DAPI, GFP, 
Cy3, and Alexa Fluor 568 were used as fluorochromes. Images 
were taken with an Axiocam (ZEI SS) Mrm rev :3 .0 –12 bit 
monochrome 2/3”CCD camera. Axiovision 4.8.1 (ZEI SS) 
was used as acquisition software. Images were further pro-
cessed using ImageJ and Photoshop (Adobe).
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Statistical analysis
Data were analyzed using Prism 6 software (GraphPad Soft-
ware). Statistical significance between groups was determined 
using unpaired Student’s t test. P < 0.05 was considered sig-
nificant. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
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